Lifescience Intellipedia Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 13.56%
- Profit Growth 8.49%
- Ebitda 33.15%
- Net Worth 40.00%
- Total Assets 77.17%
About Lifescience Intellipedia
Lifescience Intellipedia Private Limited (LIPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 April 2016 (Eight years and nine months 21 days old ). Its registered office is in Noida, Uttar Pradesh, India.
The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Mohmad Ahmed and Rakesh Shahi serve as directors at the Company.
Company Details
-
Location
Noida, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U74999UP2016PTC082614
-
Company No.
082614
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Apr 2016
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Lifescience Intellipedia?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohmad Ahmed
|
Director | 20-Apr-2016 | Current |
|
Rakesh Shahi
|
Director | 20-Apr-2016 | Current |
Financial Performance of Lifescience Intellipedia.
Lifescience Intellipedia Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.56% increase. The company also saw a slight improvement in profitability, with a 8.49% increase in profit. The company's net worth Soared by an impressive increase of 40%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lifescience Intellipedia?
In 2023, Lifescience Intellipedia had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Clival Private LimitedMohmad Ahmed and Rakesh Shahi are mutual person
-
Abha Biotechnology Private LimitedMohmad Ahmed and Rakesh Shahi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Lifescience Intellipedia?
Lifescience Intellipedia has a workforce of 68 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lifescience Intellipedia, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lifescience Intellipedia's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.